1. Home
  2. VC vs MIRM Comparison

VC vs MIRM Comparison

Compare VC & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$100.34

Market Cap

3.2B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$65.73

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
MIRM
Founded
2000
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
VC
MIRM
Price
$100.34
$65.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
11
Target Price
$129.08
$87.55
AVG Volume (30 Days)
308.0K
578.2K
Earning Date
10-23-2025
11-04-2025
Dividend Yield
1.10%
N/A
EPS Growth
N/A
N/A
EPS
11.17
N/A
Revenue
$3,759,000,000.00
$471,794,000.00
Revenue This Year
N/A
$53.78
Revenue Next Year
$3.92
$19.91
P/E Ratio
$8.95
N/A
Revenue Growth
N/A
53.66
52 Week Low
$65.10
$36.88
52 Week High
$129.10
$78.55

Technical Indicators

Market Signals
Indicator
VC
MIRM
Relative Strength Index (RSI) 40.36 35.77
Support Level $98.57 $63.48
Resistance Level $103.38 $71.98
Average True Range (ATR) 2.74 3.12
MACD 0.21 -0.49
Stochastic Oscillator 44.38 18.08

Price Performance

Historical Comparison
VC
MIRM

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: